Corticosteroid Injections for Arthritis-Related Hand Closure Difficulty
Corticosteroid injections can provide short-term pain relief in hand arthritis but have limited evidence for improving hand closure or function, particularly in osteoarthritis, and should be reserved for specific situations based on the type of arthritis and joint involvement.
Treatment Approach by Arthritis Type
For Hand Osteoarthritis
Intra-articular corticosteroid injections are generally NOT recommended for hand OA, with one important exception 1, 2:
- Do NOT routinely inject for generalized hand OA
- MAY consider injection only for painful interphalangeal (IP) joints with acute flares 1
- The 2019 ACR/Arthritis Foundation guidelines do not provide a strong recommendation for routine use in hand OA 2
Evidence for efficacy:
- A 2022 meta-analysis found oral corticosteroids showed medium effect on pain relief at 4-6 weeks (SMD -0.53), but no significant effect persisted at 3 months after stopping treatment 3
- For intra-articular injections in hand OA: no significant effect on pain or function at 4-6 weeks or over 3-12 months 3
- Another 2022 meta-analysis showed some pain improvement (MD -5.75 on VAS) but with significant heterogeneity and limited quality evidence 4
For Rheumatoid Arthritis
Corticosteroid injections ARE recommended as part of therapy adjustment in RA 1:
- Indicated when one or few residual active joints remain despite systemic treatment
- 75% of RA patients respond within 4 days, with most experiencing pain relief 5
- PIP joints respond better than MCP joints 5
- Effect can persist for at least 3 months in responders 5
- Higher injection volumes correlate with better outcomes 5
Critical Considerations for Hand Closure
Important caveat: The evidence focuses primarily on pain relief, not specifically on improving hand closure or grip strength. One study showed:
- Grip strength improved from 75.3 to 85.9 N after one week 6
- Range of motion improved from 87° to 102° 6
- However, stiffness may transiently increase in the first 24 hours post-injection, consistent with crystal synovitis 6
Practical Implementation
If proceeding with injection:
- Avoid overuse of the injected joint for 24 hours, but do not immobilize 1
- Maximum of 4 injections per year at minimum 3-month intervals 7
- Preferred agents: Betamethasone or methylprednisolone 7
- Shared decision-making is essential - explain limited long-term benefits 1
When to reconsider injection:
- If previous injections provided no benefit
- In generalized hand OA without acute flare
- When systemic treatment options haven't been optimized (for RA)
Common Pitfalls
- Do not inject without proper diagnosis - rule out infection and other contraindications first 1
- Do not expect functional improvement in painless joints - the goal is symptom relief, not structural improvement 1
- Do not use as monotherapy in RA - injections are adjunctive to systemic disease-modifying treatment 1
- Beware of transient glucose elevation in diabetic patients, particularly days 1-3 post-injection 1
Bottom Line for Hand Closure
For inability to close the hand due to arthritis:
- If due to RA with active synovitis: Injection may help as part of comprehensive treatment
- If due to OA: Injection unlikely to provide meaningful functional improvement beyond short-term pain relief
- Address the underlying disease with appropriate systemic therapy rather than relying on local injections alone
- Consider occupational therapy and hand exercises as these are not addressed by injections but may directly improve hand closure